Esperion Therapeutics Stock Charts (NASDAQ:ESPR)

Add to My Stocks
$33.19 $0.22 (0.67%) ESPR stock closing price May 24, 2017 (Closing)

Esperion Therapeutics Net Income Chart

Quarterly Annual
  • Download
    • Download PNG image
    • Download JPEG image
    • Download SVG image
    • Download PDF document
Compare with
AEGR net income
AKAO net income
GEMP net income
LCI net income
Esperion Therapeutics Net Income: Esperion Therapeutics Inc saw an an increase of net income by 39.99% from 2016-Q4 to 2017-Q1. The net income or bottom line is a line item in the income statement of a company's financials. The net profit is obtained by removing the COGS, expenses, and taxes from the firm's total income. The net income is always calculated for a given accounting period.